A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes-Reference-Cited by-同舟云学术

A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes

Published:2020-10-26 Issue:6 Volume:3 Page:1199-1210
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Woodward David F.¹^ORCID,Wang Jenny W.¹,Spada Clayton S.¹,Carling Robert W.²,Martos Jose L.²,Pettit Simon²,Kangasmetsa Jussi²,Waterbury L. David³,Lawrence Matthew⁴,Hu Wenzheng⁴,Poloso Neil J.¹

Affiliation:

1. Research and External Scientific Innovation, Allergan Inc., Irvine, California 92612, United States

2. Discovery Department, Selcia Ltd., Ongar, Essex, CM5 0GS, U.K.

3. Raven Biosolutions LLC, San Carlos, California 94070, United States

4. RxGen Inc., Hamden, Connecticut 06511, United States

Funder

Allergan

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.0c00118

Reference31 articles.

1. International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

2. Multitargeting of selected prostanoid receptors provides agents with enhanced anti‐inflammatory activity in macrophages

3. In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti‐inflammatory effects

4. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2α, PGF2α-1-methyl ester, and PGF2α-1-isopropyl ester

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostanoid signaling in retinal vascular diseases;Prostaglandins & Other Lipid Mediators;2024-10

2. Building on endogenous lipid mediators to design synthetic receptor ligands;European Journal of Medicinal Chemistry;2022-03